Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q35038304

about

Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells.Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma

P2860

Q26784412-B44CD130-FF39-43EB-B672-F51CD53EE468 Q28066038-C616A2FF-A822-4DC3-851F-1D97425B4B3A Q28080153-A3C666B3-163A-4099-8B0C-D8AA1385039C Q33889165-0D186B5B-95F5-4C3F-A0E4-6111C3858964 Q37472263-6CD66A53-3007-4C7B-B73F-982B564C4932 Q41505555-0802D0D1-E177-4CF5-92AA-C2ECA17121F8 Q43375856-1F2E2711-5B1A-471B-91A9-20EB73BFAC53 Q46480547-C0DB7CC3-E2A6-49AE-AEE9-6D61411A5CE6 Q47096853-A4663533-B019-4798-8D8B-0D57C8FFB978 Q56956744-5B830A13-F3F8-4F5B-91DC-514EA218AFFA

P2860

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q35038304

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@ast

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@en

type

label

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@ast

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@en

prefLabel

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@ast

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@en

P1433

Q35038304-CDD68842-BA7E-4755-BCB0-AE3A403C8E11

P1476

Q35038304-2A338063-36E0-417E-8F29-05F8F86D24D7

P2093

Q35038304-0DD0E29B-F8E5-425E-BB84-3776F15E3B6B

Q35038304-12497437-4DD5-4B3F-A560-5B42AB847215

Q35038304-9103386A-FF88-45F8-A2BF-3BC2E98ACF31

P2860

Q35038304-0DE5542D-94C6-4BD3-8525-EAFC7F1FD0A3

Q35038304-16AF941A-3044-45B8-9C36-66C2E33FDA64

Q35038304-1C2849E3-2651-44D4-9732-7BF557799164

Q35038304-1C437896-28BB-4440-82CF-D0574EDFCECF

Q35038304-1E0E070C-22E3-4C0F-9F12-CE855C0B9746

Q35038304-1FF4CB7C-8EBA-485F-B712-40A20F5593F2

Q35038304-25F740E7-F6A4-470C-A692-16FA56D7CBBB

Q35038304-272DB838-2C46-4AB8-8B0B-41B69EBF76D1

Q35038304-3A50E109-9B18-4E57-9CBD-D6FC55040662

Q35038304-3EEC222C-C2EC-4458-9FAB-12B5B2A4334F

P304

Q35038304-F2555358-7EA4-483F-967B-D7055D1EB263

P31

Q35038304-BF1089BA-7996-48E7-A311-E01201DAFF72

P356

Q35038304-E0BC4956-AC7E-4A2E-9B79-B341171D667D

P407

Q35038304-99947B75-0539-45D6-BE2A-AD1F9240D497

P433

Q35038304-9EB9E40D-1881-495B-9883-AF8177A7BD14

P478

Q35038304-4208B690-37B2-4CFA-ACD1-97DF64361BCC

P50

Q35038304-49909C12-56A1-4265-A107-41B45C0E3F1E

P577

Q35038304-77F67378-6FDE-4681-94B3-E598D06EF5D8

P5875

Q35038304-22434B35-2901-47B1-A687-17CD0F1CA801

P698

Q35038304-FA183431-6A19-4399-B20A-C2E9AADB891C

P932

Q35038304-F795EACC-51F8-46E9-9F9C-691A9E361D0E

P356

JOURNAL.PONE.0117274

P1433

P1476

Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma

@en

P2093

Litao Xu

http://www.w3.org/2001/XMLSchema#string

Peng Wang

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Meng

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

A microRNA expression signature of human solid tumors defines cancer gene targets

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

MicroRNA expression, survival, and response to interferon in liver cancer

Management of hepatocellular carcinoma: An update

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA expression profiles classify human cancers

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Extensive modulation of a set of microRNAs in primary glioblastoma

miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway

P304

e0117274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0117274

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271773127

http://www.w3.org/2001/XMLSchema#string

P698

25642945

http://www.w3.org/2001/XMLSchema#string

P932

4313939

http://www.w3.org/2001/XMLSchema#string